Iranian
Biomedical Journal
Volume 27, Issue 6 (11-2023)
IBJ 2023, 27(6): 388-396 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ehsan Ilahi N, Siddiquec N, Rashid M I, Noreen M, Murad S. Decoding the Genetic and Structural Features of HPV16 E5 Oncogene in Cervical Cancer Isolates from Pakistan: A Pilot Study. IBJ 2023; 27 (6) :388-396
URL: http://ibj.pasteur.ac.ir/article-1-3884-en.html
URL: http://ibj.pasteur.ac.ir/article-1-3884-en.html
Abstract:
Background: Many anogenital cancers are caused by high-risk human papillomavirus (HPV). The most common subtype is HPV16, which is prevalent in the world, including Pakistan. Various amino acid residues in HPV16 E5 are associated with high cell cycle progression and proliferation. Lack of studies on HPV16E5 in Pakistan prompted the current study. This is the first report on the occurrence of pathogenic E5 variant of HPV16 in tissue sections obtained from invasive cervical cancerous patients in Pakistan.
Methods: A subset of 11 samples from HPV-positive biopsies were subjected to E5 gene amplification using PCR and analyzed using bioinformatics programs. The bioinformatics analysis detected mutations causing structural variations, which potentially contribute to the oncogenic properties of proteins.
Results: The two-point mutations, C3979A and G4042A, observed in isolate 11 caused the substitution of isoleucine for leucine and valine at positions 44 and 65 in E5 protein. The rest of the isolates had Leu44Val65 amino acids. Intratypic variations and phylogenetic analysis revealed that the majority of the isolates were closely clustered with European-Asian lineage. Moreover, C3979A and G4042A contributed to higher degree of interactions with host receptors, i.e. epidermal growth factor receptor (EGFR).
Conclusion: This is the first study reporting HPV16 variants in a Pakistani population based on variations in the E5 region. Our findings indicate that isolate 11 has a strong interaction with the intracellular domain of EGFR, which may enhance the generation of downstream signals. Since this was a pilot study to explore E5 gene mutation, future studies with large samples are absolutely needed.
Methods: A subset of 11 samples from HPV-positive biopsies were subjected to E5 gene amplification using PCR and analyzed using bioinformatics programs. The bioinformatics analysis detected mutations causing structural variations, which potentially contribute to the oncogenic properties of proteins.
Results: The two-point mutations, C3979A and G4042A, observed in isolate 11 caused the substitution of isoleucine for leucine and valine at positions 44 and 65 in E5 protein. The rest of the isolates had Leu44Val65 amino acids. Intratypic variations and phylogenetic analysis revealed that the majority of the isolates were closely clustered with European-Asian lineage. Moreover, C3979A and G4042A contributed to higher degree of interactions with host receptors, i.e. epidermal growth factor receptor (EGFR).
Conclusion: This is the first study reporting HPV16 variants in a Pakistani population based on variations in the E5 region. Our findings indicate that isolate 11 has a strong interaction with the intracellular domain of EGFR, which may enhance the generation of downstream signals. Since this was a pilot study to explore E5 gene mutation, future studies with large samples are absolutely needed.
Type of Study: Short Communication |
Subject:
Molecular Microbiology
References
1. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. International journal of cancer 1996; 69(5): 364-368.
https://doi.org/10.1002/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3 [DOI:10.1002/(SICI)1097-0215(19961021)69:53.0.CO;2-3]
2. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 1998; 352(9138): 1441-1442. [DOI:10.1016/S0140-6736(05)61263-9]
3. Zehbe I, Wilander E, Delius H, Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Research 1998; 58(4): 829-833.
4. Xi LF, Demers GW, Koutsky LA, Kiviat NB, Kuypers J, Watts DH, Holmes KK, Galloway DA. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. The journal of infectious diseases 1995; 172(3): 747-755. [DOI:10.1093/infdis/172.3.747]
5. Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer epidemiology, biomarkers and prevention 2007; 16(1): 4-10. [DOI:10.1158/1055-9965.EPI-06-0670]
6. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Kahn T, Kiviat N, Lancaster W, Mavromara-Nazos P. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. Journal of virology 1993; 67(11): 6413-6423. [DOI:10.1128/jvi.67.11.6413-6423.1993]
7. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. Journal of virology 1995; 69(12): 7743-7753. [DOI:10.1128/jvi.69.12.7743-7753.1995]
8. Burk RD, Harari A, Chen Z. Human papillomavirus genome variants. Virology 2013; 445(1-2): 232-243. [DOI:10.1016/j.virol.2013.07.018]
9. Borzacchiello G, Roperto F, Campo MS, Venuti A. 1st International workshop on Papillomavirus E5 oncogene-a report. Virology 2010; 408(2): 135-137. [DOI:10.1016/j.virol.2010.09.015]
10. Conrad M, BubbVJ, Schlegel R The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. Journal of virology 1993; 67(10): 6170-6178. [DOI:10.1128/jvi.67.10.6170-6178.1993]
11. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Human pathology 1992; 23(2): 117-128. [DOI:10.1016/0046-8177(92)90232-R]
12. Kell B, Jewers RJ, Cason J, Pakarian F, Kaye JN, Best JM. Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides. The journal of general virology 1994; 75( Pt 9): 2451-2456. [DOI:10.1099/0022-1317-75-9-2451]
13. Biswas C, Kell B, Mant C, Jewers RJ, Cason J, Muir P, Raju KS, Best JM. Detection of human papillomavirus type 16 early-gene transcription by reverse transcription-PCR is associated with abnormal cervical cytology. Journal of clinical microbiology 1997; 35(6): 1560-1564. [DOI:10.1128/jcm.35.6.1560-1564.1997]
14. Hsieh CH, Tsao YP, Wang CH, Han CP, Chang JL, Lee JY, Chen SL. Sequence variants and functional analysis of human papillomavirus type 16 E5 gene in clinical specimens. Archives of virology 2000; 145(11): 2273-2284. [DOI:10.1007/s007050070020]
15. Regan JA, Laimins LA. Bap31 is a novel target of the human papillomavirus E5 protein. Journal of virology 2008; 82(20): 10042-10051. [DOI:10.1128/JVI.01240-08]
16. Cortese MS, Ashrafi GH, Campo MS. All 4 di-leucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I downregulation activity and E5 endomembrane localization. International journal of cancer 2010; 126(7): 1675-1682. [DOI:10.1002/ijc.25004]
17. Rodriguez MI, Finbow ME, Alonso A. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. Oncogene 2000; 19(33): 3727-3732. [DOI:10.1038/sj.onc.1203718]
18. Hwang ES, Nottoli T, Dimaio D. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology 1995; 211(1): 227-233. [DOI:10.1006/viro.1995.1395]
19. Gu Z, Matlashewski G. Effect of human papillomavirus type 16 oncogenes on MAP kinase activity. Journal of virology 1995; 69(12): 8051-8056. [DOI:10.1128/jvi.69.12.8051-8056.1995]
20. Zyzak LL, MacDonald L M, Batova A, Forand R, Creek KE, Pirisi L. Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratino-cytes. Cell growth and differentiation: the molecular biology journal of the american association for cancer research 1994; 5(5): 537-547.
21. Wetherill LF, Holmes KK, Verow M, Müller M, Howell G, Harris M, Fishwick C, Stonehouse N, Foster R, Eric Blair G, Griffin S. High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors. Journal of virology 2012; 86(9): 5341-5351. [DOI:10.1128/JVI.06243-11]
22. Bravo IG, Alonso A. Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. Journal of virology 2004; 78(24): 13613-13626. [DOI:10.1128/JVI.78.24.13613-13626.2004]
23. Hao M, Wu XZ, XL Wang, Bian ML, Liu HT. [Human papillomavirus type 16 E5 sequence evolution analysis]. Chinese journal of experimental and clinical virology 2009; 23(6): 452-454.
24. Yamada T, Manos MM, Peto J, Greer CE, MunozN, Bosch F X, Wheeler CM. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. Journal of virology 1997; 71(3): 2463-2472. [DOI:10.1128/jvi.71.3.2463-2472.1997]
25. Ilahi NE, Naiyar Hashmi S, Anwar S, Murad S. Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples. Journal of cancer research and clinical oncology 2016; 142(11): 2367-2373. [DOI:10.1007/s00432-016-2227-z]
26. Siddiqa A, Zainab M, Qadri I, Bhatti MF, Parish JL. Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan. Viruses 2014; 6(7): 2762-2777. [DOI:10.3390/v6072762]
27. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. The journal of general virology 1995; 76( Pt 4): 1057-1062. [DOI:10.1099/0022-1317-76-4-1057]
28. Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, Stolz E, Herbrink P. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. Journal of clinical microbiology 1996; 34(3): 745-747. [DOI:10.1128/jcm.34.3.745-747.1996]
29. Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic acids research 1988; 16(22): 10881-10890. [DOI:10.1093/nar/16.22.10881]
30. Kennedy IM, Haddow JK, Clements JB, A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. Journal of virology 1991; 65(4): 2093-2097. [DOI:10.1128/jvi.65.4.2093-2097.1991]
31. National Library of Medicine. Human papillomavirus type 16 isolate European German 131 type, complete genome. Availabel at: https://www.ncbi.nlm.nih.gov/ nuccore/AF536179.1.
32. Smith B, ChenZ, Reimers L, van Doorslaer K, Schiffman M, Desalle R, Herrero R, Yu K, Wacholder S, Wang T, Burk RD. Sequence imputation of HPV16 genomes for genetic association studies. PLoS one 2011. 6(6): e21375. [DOI:10.1371/journal.pone.0021375]
33. Chen Z, Terai M, Fu L, Herrero R, DeSalle R, Burk RD. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. Journal of virology 2005; 79(11): 7014-7023. [DOI:10.1128/JVI.79.11.7014-7023.2005]
34. National Library of Medicine. Human papillomavirus type 16 Asian-American variant, complete genome Available at: https://www.ncbi.nlm.nih.gov/nuccore/ AF402678.
35. Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, Lescot M, Claverie JM, Gascuel O. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic acids research 2008; 36(Web Server issue): W465-469. [DOI:10.1093/nar/gkn180]
36. Dereeper A, Audic S, Claverie JM, Blanc G. BLAST-EXPLORER helps you building datasets for phylogenetic analysis. BMC evolutionary biology 2010; 10: 8. [DOI:10.1186/1471-2148-10-8]
37. Konagurthu AS, Whisstock JC, Stuckey PJ, Lesk AM. MUSTANG: a multiple structural alignment algorithm. Proteins 2006; 64(3): 559-574. [DOI:10.1002/prot.20921]
38. Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, Fagan P, Marvin J, Padilla D, Ravichandran V, Schneider B, Thanki N, Weissig H, Westbrook JD, Zardecki C. The protein data bank. Acta crystallographica. Section D, Biological crystallography 2002; 58(6): 899-907. [DOI:10.1107/S0907444902003451]
39. Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C,Beglov D, Vajda S. The ClusPro web server for protein-protein docking. Nature protocols 2017; 12(2): 255-278. [DOI:10.1038/nprot.2016.169]
40. Letsolo BT, Faust H, Ekblad L, Wennerberg, Ola Forslund J. Establishment and characterization of a human papillomavirus type 16-positive tonsillar carcinoma xenograft in BALB/c nude mice. Head and neck 2016; 38(3): 417-425. [DOI:10.1002/hed.23918]
41. Tornesello ML, Duraturo ML, Buonaguro L, Vallefuoco G, Piccoli R, Palmieri S, Buonaguro FM. Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infectious agents and cancer 2007; 2: 1. [DOI:10.1186/1750-9378-2-1]
42. Stoppler MC, Ching K, Stöppler H, Clancy K, Schlegel R, Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. Journal of virology 1996; 70(10): 6987-6993. [DOI:10.1128/jvi.70.10.6987-6993.1996]
43. Nath R, Mant CA, Kell B, Cason J, Bible JM. Analyses of variant human papillomavirus type-16 E5 proteins for their ability to induce mitogenesis of murine fibroblasts. Cancer cell international 2006; 6(1): 19. [DOI:10.1186/1475-2867-6-19]
44. Eriksson A, Herron JR, Yamada T, Wheeler CM. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. The journal of general virology 1999; 80( Pt 3): 595-600. [DOI:10.1099/0022-1317-80-3-595]
45. Halpern AL, McCance DJ. Papillomavirus E5 Proteins. Transformation, 1996. 9: 52. Available at: https://pave. niaid.nih.gov/lanl-
46. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324(1): 17-27. [DOI:10.1016/j.virol.2004.03.033]
47. Ashrafi GH, Haghshenas M, Marchetti B, Campo MS. E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. International journal of cancer 2006; 119(9): 2105-2112. [DOI:10.1002/ijc.22089]
48. Campo MS, Graham SV, Cortese MS, Ashrafi GH, Araibi EH, Dornan ES, Miners K, Nunes C, Man S. HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells. Virology 2010; 407(1): 137-142. [DOI:10.1016/j.virol.2010.07.044]
49. Zhang B, Spandau DF, Roman A. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis. Journal of virology 2002; 76(1): 220-231. [DOI:10.1128/JVI.76.1.220-231.2002]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |